Yatsen Holding Limited

Yatsen Holding Limited Q3 2025 Earnings Recap

YSG Q3 2025 November 17, 2025

Get alerts when YSG reports next quarter

Set up alerts — free

Yatsen Holding Limited reported a robust 47.5% year-over-year growth in total net revenues for Q3 2025, marking its fourth consecutive quarter of revenue growth and significantly narrowing its net loss margin.

Market Reaction

1-Day -20.32%
5-Day -7.16%
30-Day -43.2%

See YSG alongside your other holdings

Add to your portfolio — free

Key Takeaways

  • Skincare brands experienced exceptional growth of 83.2%, accounting for 49.2% of total revenue, underscoring a successful category upgrade strategy.
  • The net loss margin improved from 17.9% to 7%, reflecting enhanced gross margins and operational efficiencies.
  • Continued emphasis on innovation led to successful product launches and increased customer engagement, particularly in the Galani and Doctor Wu brands.
  • Yatsen remains focused on disciplined capital allocation while driving profitability through a balanced growth strategy in its brand portfolio.
This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit YSG on AllInvestView.

Get the Full Picture on YSG

Track Yatsen Holding Limited in your portfolio with real-time analytics, dividend tracking, and more.

View YSG Analysis